At-home care can address symptoms, but it can't correct the biomechanical drivers, stimulate tissue regeneration, or reverse structural degeneration that's already occurred
there was no difference in either Hb level or ESA dose outcomes in 1 of these studies, and in the other, the comparison was only of erythropoietin resistance index (ERI)
Patients with primary insulin resistance and impaired hepatic fat oxidation (common in MASLD) may respond more robustly to GLP-1 receptor agonists than those with intact metabolic flexibility the drug isn't just suppressing appetite, it's correcting a broken fuel switch
Semaglutide has been marketed for over a decade in diabetes care, and SELECT outcomes data extends beyond five years
[7] The antioxidant enzyme glutathione peroxidase 2 (Gpx2) is one out of eight known glutathione peroxidases (Gpx1-8) in humans
Molecular, physiological and clinical aspects of the iron storage protein ferritin